GENFIT TOWARDS BETTER MEDICINE

Serial Number 77532499
Registration 3786636
800

Registration Progress

Application Filed
Jul 28, 2008
Under Examination
Approved for Publication
Feb 23, 2010
Published for Opposition
Feb 23, 2010
Registered
May 11, 2010

Trademark Image

GENFIT TOWARDS BETTER MEDICINE

Basic Information

Serial Number
77532499
Registration Number
3786636
Filing Date
July 28, 2008
Registration Date
May 11, 2010
Published for Opposition
February 23, 2010
Renewal Date
May 11, 2020
Drawing Code
3

Status Summary

Current Status
Active
Status Code
800
Status Date
Jun 29, 2020
Registration
Registered
Classes
001 005 042

Rights Holder

Genfit

99
Address
885 Avenue Eugene Avinee
Loos 59120
FR

Ownership History

Genfit

Original Applicant
99
Loos FR

Genfit

Owner at Publication
99
Loos FR

Genfit

Original Registrant
99
Loos FR

Legal Representation

Attorney
Brooks R. Bruneau

USPTO Deadlines

Next Deadline
1644 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2010-05-11)
Due Date
May 11, 2030
Grace Period Ends
November 11, 2030

Application History

31 events
Date Code Type Description Documents
Jun 29, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Jun 29, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Jun 29, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 29, 2020 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Apr 17, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
May 11, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Jul 6, 2016 C15P O REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Jul 6, 2016 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Jul 5, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
May 10, 2016 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
May 11, 2010 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 23, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 23, 2010 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 14, 2010 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 23, 2009 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Dec 23, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 17, 2009 MAIL I PAPER RECEIVED Loading...
Jun 15, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 15, 2009 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 15, 2009 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 23, 2009 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
May 23, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 18, 2009 ALIE A ASSIGNED TO LIE Loading...
May 15, 2009 MAIL I PAPER RECEIVED Loading...
Nov 13, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 13, 2008 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 13, 2008 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 5, 2008 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 1, 2008 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED Loading...
Jul 31, 2008 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
[ Enzymatic preparations for scientific and research purposes in the medical, or pharmaceutical fields ]
Class 005
[ Pharmaceutical products for the treatment of cardiovascular diseases, dermatological diseases, disorders in the central nervous system, cancers, asthma, allergies, lipidic disorders, obesity and diabetes; sanitary preparations for medical use; biological preparations for medical use; slimming medical preparations, namely, diet pills, tablets, sachets of powder, capsules, syrups; cultures of microorganisms for medical, pharmaceutical or veterinary use; culture media for use in bacteriology; cell culture preparations of eucaryotic cell lines or microorganisms for medical or pharmaceutical use, in particular in gene therapy and cell therapy; biologically active compounds being components of pharmaceutical preparations for treating metabolic disorders in human beings and animals, in particular in the case of cardiovascular diseases, dermatological diseases, disorders in the central nervous system, cancers, asthma, allergies, lipidic disorders, obesity and diabetes; kits comprising cells, nucleic acids, proteins or reagents for the preparation or the selection of biologically active compounds or cells for medical purposes; diagnostic preparations for medical use comprising chemical reagents for in-vivo, ex-vivo or in-vitro use; diagnosis reagents for medical or veterinary use; sanitary preparations for medical use; dietetic substances for medical use; dietetic foodstuffs for medical use; food supplements for medical use; enzyme preparations for medical or veterinary use, namely, enzyme food supplements and animal feed additives in the nature of enzymes for use in animal feeds to assist in digestion ]
Class 042
Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical [ or veterinary ] fields; basic and applied research in the medical field; [ technical research in the scientific field; ] pharmaceutical research for the screening and selection of molecules for drug development; scientific research for the development and validation of biological tests, of cell tests and of genetic tests; [ development of new technology for others in the field of functional genomics to identity, characterize, validate or develop biologically active molecules; ] biological research via analysis of biological substances in biologic fluids [ ; computer programming in the field of scientific research and for the pharmaceutical industry; analysis of technical medical products or processes for scientific and research purposes in the medical, pharmaceutical or biotechnological fields; professional consultancy, not connected with the conduct of business, in the fields of scientific research and for the pharmaceutical industry; research and development of new pharmaceutical products for third parties; rental of computer hardware, namely, access time to a scientific data base server centre ]

Additional Information

Design Mark
The mark consists of the word "GENFIT" and a portion of the partial sphere appearing in blue. The words "Towards Better Medicine" and a portion of the partial sphere appearing in orange. The slanted lining on the partial sphere appears in white.
Color Claim
The color(s) Blue, white and orange is/are claimed as a feature of the mark.

Classification

International Classes
001 005 042